IL185805A0 - Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments - Google Patents
Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicamentsInfo
- Publication number
- IL185805A0 IL185805A0 IL185805A IL18580507A IL185805A0 IL 185805 A0 IL185805 A0 IL 185805A0 IL 185805 A IL185805 A IL 185805A IL 18580507 A IL18580507 A IL 18580507A IL 185805 A0 IL185805 A0 IL 185805A0
- Authority
- IL
- Israel
- Prior art keywords
- benzimidazoles
- pyrrolidino
- medicaments
- bicyclic
- substituted
- Prior art date
Links
- 125000002619 bicyclic group Chemical group 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical class C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 abstract 1
- 208000020450 carbohydrate metabolism disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 208000017745 inborn carbohydrate metabolic disease Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005012872A DE102005012872A1 (de) | 2005-03-19 | 2005-03-19 | Substituierte, bizyklische 8-Pyrrolidino-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP2006/002055 WO2006099940A1 (de) | 2005-03-19 | 2006-03-07 | Substituierte, bizyklische 8-pyrrolidino-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL185805A0 true IL185805A0 (en) | 2008-01-06 |
Family
ID=36579682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL185805A IL185805A0 (en) | 2005-03-19 | 2007-09-06 | Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7569700B2 (https=) |
| EP (1) | EP1863817B1 (https=) |
| JP (1) | JP2008533064A (https=) |
| AT (1) | ATE396997T1 (https=) |
| AU (1) | AU2006226637A1 (https=) |
| BR (1) | BRPI0608456A2 (https=) |
| CA (1) | CA2602229A1 (https=) |
| DE (2) | DE102005012872A1 (https=) |
| IL (1) | IL185805A0 (https=) |
| MX (1) | MX2007010841A (https=) |
| WO (1) | WO2006099940A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102260265B (zh) | 2010-05-24 | 2015-09-02 | 上海阳帆医药科技有限公司 | 六氢吡咯[3,4-b]吡咯衍生物、其制备方法及其用途 |
| TW202220968A (zh) * | 2016-01-29 | 2022-06-01 | 美商維它藥物有限責任公司 | ＲＯＲ－γ調節劑 |
| JP7640458B2 (ja) | 2018-10-05 | 2025-03-05 | アンナプルナ バイオ インコーポレイテッド | Ａｐｊ受容体活性に関連する状態を処置するための化合物および組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60023100T2 (de) * | 2000-01-05 | 2006-07-06 | Pfizer Inc. | Benzimidazol-Verbindungen zur Verwendung als ORL1-Rezeptor-Antagonisten |
| WO2002046173A1 (en) * | 2000-12-06 | 2002-06-13 | F. Hoffmann-La Roche Ag | Fused heteroaromatic glucokinase activators |
| US6855708B2 (en) * | 2001-03-20 | 2005-02-15 | Merck & Co., Inc. | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| CA2494102A1 (en) * | 2002-07-30 | 2004-02-05 | Banyu Pharmaceutical Co., Ltd. | Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| ATE450533T1 (de) * | 2003-02-14 | 2009-12-15 | Glaxo Group Ltd | Carboxamidderivate |
| WO2005035526A1 (en) * | 2003-10-09 | 2005-04-21 | Argenta Discovery Ltd. | Bicyclic compounds and their therapeutic use |
-
2005
- 2005-03-19 DE DE102005012872A patent/DE102005012872A1/de not_active Withdrawn
-
2006
- 2006-03-07 DE DE502006000850T patent/DE502006000850D1/de not_active Expired - Lifetime
- 2006-03-07 CA CA002602229A patent/CA2602229A1/en not_active Abandoned
- 2006-03-07 BR BRPI0608456-7A patent/BRPI0608456A2/pt not_active Application Discontinuation
- 2006-03-07 AU AU2006226637A patent/AU2006226637A1/en not_active Abandoned
- 2006-03-07 EP EP06723254A patent/EP1863817B1/de not_active Expired - Lifetime
- 2006-03-07 MX MX2007010841A patent/MX2007010841A/es not_active Application Discontinuation
- 2006-03-07 JP JP2008501194A patent/JP2008533064A/ja not_active Abandoned
- 2006-03-07 AT AT06723254T patent/ATE396997T1/de not_active IP Right Cessation
- 2006-03-07 WO PCT/EP2006/002055 patent/WO2006099940A1/de not_active Ceased
-
2007
- 2007-09-06 IL IL185805A patent/IL185805A0/en unknown
- 2007-09-14 US US11/855,224 patent/US7569700B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1863817A1 (de) | 2007-12-12 |
| MX2007010841A (es) | 2007-11-09 |
| WO2006099940A8 (de) | 2006-11-09 |
| AU2006226637A1 (en) | 2006-09-28 |
| EP1863817B1 (de) | 2008-05-28 |
| US20080090890A1 (en) | 2008-04-17 |
| ATE396997T1 (de) | 2008-06-15 |
| DE502006000850D1 (de) | 2008-07-10 |
| JP2008533064A (ja) | 2008-08-21 |
| US7569700B2 (en) | 2009-08-04 |
| BRPI0608456A2 (pt) | 2010-01-05 |
| CA2602229A1 (en) | 2006-09-28 |
| DE102005012872A1 (de) | 2006-09-28 |
| WO2006099940A1 (de) | 2006-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2009003275A (es) | Derivados de azacicloalcanos como inhibidores de estearoil-coenzima a delta-9 desaturasa | |
| NO20090064L (no) | Pyrasoler som glucokinase aktivatorer | |
| PH12016502294A1 (en) | Novel fatty acids and their use in conjugation to biomolecules | |
| CO6410287A2 (es) | Composición farmacéutica, forma farmacéutica, procedimiento para su preparación, métodos de tratamiento y usos de la misma | |
| PH12013500808A1 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
| UA100384C2 (en) | Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative | |
| EA200900896A1 (ru) | Соединения-агонисты гетероциклических рецепторов (варианты), фармацевтическая композиция на их основе, способ лечения диабета и метаболических расстройств, способ стимулирования выработки инсулина (варианты) и способы снижения уровня глюкозы и триглицеридов в крови посредством указанных соединений | |
| WO2008108958A3 (en) | Benzimidazole derivatives and methods of use thereof | |
| HRP20130406T1 (hr) | Medikamenti s aktivnošä†u prema receptoru hm74a | |
| NO20091229L (no) | Kombinasjonsterapi med SGLT-2 inhibitorer og deres farmasoytiske sammensetninger | |
| EA201300550A1 (ru) | Фармацевтическая композиция, способы лечения и их применение | |
| BRPI0911035B8 (pt) | ativadores de pirrolidinona glicoquinase | |
| MX2010001560A (es) | Composicion farmaceutica que comprende un inhibidor de sglt2 en combinacion con un inhibidor de dpp-iv. | |
| UA101393C2 (ru) | КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ТРИАЗОЛА ДЛЯ ЛЕЧЕНИЯ β-АМИЛОИДОЗОВ И СИНУКЛЕИНОПАТИЙ | |
| MY141034A (en) | Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use | |
| PH12014502448A1 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
| EA201171087A1 (ru) | СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ | |
| TN2009000275A1 (en) | Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome | |
| NO20054408L (no) | 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose | |
| IL185805A0 (en) | Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments | |
| MX2009002906A (es) | Derivados de piridina para el tratamiento de trastornos metabolicos relacionados con la resistencia a insulina o hiperglicemia. | |
| WO2006120574A3 (en) | Analogs of 4-hydroxyisoleucine and uses thereof | |
| TW200621732A (en) | Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals | |
| MY156174A (en) | 4-(1,2,4-dioxazol-3-yl)benzamides for the treatment of diabetes and obesity | |
| EA201171368A1 (ru) | Новые гетероциклические соединения |